Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
There are more than 10 dozen anti-HIV drugs in the developmental pipeline that pharmaceutical manufacturers and other research institutions are working on; that's roughly 50% more than were being worked on a year ago. The entry inhibitor category continues to show strong promise with 40 candidates'15 more than this time last year. Entry Inhibitors( Medication Name, Stage of Development, Developer) ' 15D, Preclinical, National Cancer Institute ' 15K, Preclinical, National Cancer Institute ' AK602, Phase I, Kumamoto University ' AMD3451 CCR5-CXCR4 blocker), Preclinical, Anormed ' Betulinic acid derivatives; Preclinical; University of North Carolina, Duke University, Vanderbilt University ' BMS-378806 (gp120 blocker), Phase I, Bristol-Myers Squibb ' CCR5mAb004 (CCR5 blocker), Preclinical, Human Genome Sciences ' D5 (artificial gp41 blocker), Preclinical, Merck ' DP-178 (fusion inhibitor), Preclinical, Weizmann Institute ' GBV-C (virus increases chemokines, including CCR5 blockers), Preclinical, University of Iowa ' gp41 inhibitor, Preclinical, New York Blood Center ' gp41 inhibitor, Preclinical, Locus Pharmaceuticals ' gp120-gp41 disulfide bond; Preclinical; Amsterdam Mathematical Center, Cornell University, University of Illinois at Chicago ' IC9564, Preclinical, Duke University ' Indolicidin, Preclinical,National Institutes of Health ' KD-247 (CCR5 blocker), Preclinical, Kumamoto University ' KRH-2731 (CXCR4 blocker), Preclinical, Kureha ''KRH-3140 (CXCR4 blocker), Preclinical, Kureha ' KRH-3955 (CXCR4 blocker), Preclinical, Kureha ''Maraviroc/UK-427 (CCR5 blocker), Phase III, Pfizer ''MDX-010, Preclinical, Medarex ' Monoclonal FAbs (gp41 blocker), Preclinical, National Institutes of Health ''NB-2 (gp41 blocker), Preclinical, Shibo and Kumar ' NB-64 (gp41 blocker), Preclinical, Shibo and Kumar ''NSC 13778 (gp120 blocker), Preclinical, SAIC-National Cancer Institute ' PRO-140 (monoclonal antibody), Phase I, Progenics ' Pyrrolidine (CCR5 blocker), Preclinical, Merck ' RANTES analogs (CCR5 blockers), Preclinical, University of Geneva ' RC-112, Preclinical, CDC's AIDS, STD, and TB Laboratory Research ' Retrocyclin-1, Preclinical, CDC's AIDS, STD, and TB Laboratory Research ' Sifuvirtide, Preclinical, Fusogen ' SP-01 A, Preclinical, Samaritan ' SP-10, Preclinical, Samaritan ' TAK-652 (CCR5 blocker), Preclinical, Takeda ' TNX-355 (monoclonal antibody), Phase II, Tanox and Biogen ' TR-999, Preclinical, Trimeris and Roche ' TR-1144, Preclinical, Trimeris and Roche ' UMIST, Preclinical, Genetic Innovation Network ' Vicriviroc/SCH-D (CCR5 blocker), Phase II, Schering Plough ' Zinc finger protein nucleases (CCR5 blockers), Preclinical, Sangamo Biosciences Integrase Inhibitors(Medication Name, Stage of Development, Developer) ' AVX-I, Preclinical, Avexa ' Beta-diketo acids, Preclinical, University of Parma and University of Sassari ' Carbazole derivative, Preclinical, Japan's National Institute of Infectious Diseases ' GSK-810871, Preclinical, GlaxoSmithKline ' Indolicidin, Preclinical, National Cancer Institute ' GS-9137 (JTK-303), Phase II, Gilead Sciences and Japan Tobacco ' ITI-367, Preclinical, George Washington University ' L-second generation, Preclinical, Merck ' MK-0518, Phase III, Merck ' Monophores, Preclinical, Sunesis ' Mycelium integrasone (fungal polyketide), Preclinical, Merck ' PL-2500, Preclinical, Procyon Biopharma ' Styrylquinoline derivatives, Preclinical, BioAlliance Pharma ' Theophyline, Preclinical, Thomas Jefferson University ' V-165, Preclinical, Rega Institute Maturation Inhibitors(Medication Name, Stage of Development, Developer) ' Alpha HGA, Phase I, Tripep ' Betulinic acid derivatives (entry, maturation inhibitors); Preclinical; University of North Carolina, Duke University, Vanderbilt University ' Chloroquine, Preclinical, Catholic University of Rome ' enJS56A1, Preclinical, University of Georgia ' PA-457 (capsid inhibitor), Phase II, Vitex ' RPI-MN, Preclinical, ReceptoPharm ' UK-201844, Preclinical, Pfizer Nonnucleoside Reverse Transcriptase Inhibitors(Medication Name, Stage of Development, Developer) ' BILR 355 BS, Phase I/II, Boehringer-Ingelheim ' DOT (dioxolane thymidine), Phase I, University of Georgia ' GS9148, Preclinical, Gilead Sciences ' GSK-695634, Phase I, GlaxoSmithKline ' MIV-170, Preclinical, Medivir ' NVP C-8 substituent, Preclinical, Boehringer-Ingelheim ' Oligodeoxi-nucleotides, Preclinical, University of Zurich ' PBO-15c (pyrrolobenzoxazepinone), Preclinical, University of Siena ' Phenylthiazoylamines, Preclinical, Yale University ' Pyridinone derivatives, Preclinical, Rutgers University ' Quinolones, Preclinical, Wellcome Trust ' S-DABO derivatives, Preclinical, China's Fudan University ' SMP-610, Preclinical, Advanced Life Sciences ' SMP-717, Preclinical, Advanced Life Sciences ' Thiazol derivatives, Preclinical, Japan's Institute for Virus Research ' TMC-125 (etravirine), Phase III, Tibotec and Johnson & Johnson ' TMC-278 (diarylpyrimidine or DAPY), Phase II, Tibotec ' Tricyclic NNRTI, Preclinical, Bristol-Myers Squibb Nucleoside Reverse Transcriptase Inhibitors(Medication Name, Stage of Development, Developer) ' 4-Ed4T, Preclinical, Kagoshima University ' AVX754, Phase I/II, Avexa ' BPH-218, Preclinical, University of Pittsburgh ' Branched 3 primers, Preclinical, University of Illinois ' Compound X, Preclinical, Tibotec ' D-FDOC, Preclinical, Emory University ' Dinucleoside polyphosphates, Preclinical, University of Miami ' DOT-TP, Preclinical, Emory University ' dTTP, Preclinical, University of Rochester ' E2-FdA, Preclinical, Kumamoto University ' Elvucitabine (ACH-126), Phase II, Achillion ' Herpesvirus saimiri, Preclinical, Temple University ' KMMP05, Preclinical, National Cancer Institute ' KP-1461, Phase I/II, Koronis ' Racivir, Phase I/II, Pharmasset ' Stampidine, Preclinical, Parker Hughes Institute ' Thiovir, Preclinical, Adventrx ' Triol, Preclinical, Cruz Foundation Protease Inhibitors(Medication Name, Stage of Development, Developer) ' A-681799, Preclinical, Abbott Laboratories ' Beta-lactams, Preclinical, University of Debrecen ' Brecanavir (GSK-640385), Phase II, GlaxoSmithKline ' GRL-02031, Preclinical, Kumamoto University ' PPL-100, Preclinical, Procyon Biopharma ' SPI-256, Preclinical, Sequoia ' UIC02031, Preclinical, Kumamoto University Others(Medication Name, Stage of Development, Developer) ' Alpha-v integrins, Preclinical, irsiCaixa Foundation and Merck ' BL-1050 (regulatory protein inhibitor), Preclinical, BioLine Rx ' CDK inhibitor, Preclinical, Gilead Sciences ' CNI-1493 (rev inhibitor), Preclinical, Heinrich Pette Institute ' Curcumin/diferuloylmethane (tat inhibitor), Preclinical, Jawaharlal Nehru Center ' Cycloamides, Phase I, University of Illinois ' Glycodendrimers (lipid raft carbohydrates), Preclinical, Penn State University ' HRG214 (caprine IgG), Preclinical, Virionyx ' IM (CDK9 inhibitor), Preclinical, Institute of Human Virology ' KU-55933 (ATM kinase inhibitor), Preclinical, Kudos Pharma ' MDI-P (electrolyzed free radical), Preclinical, Medical Discoveries ' Mifepristone (glucocorticoid antagonist), Phase I, University of Pittsburgh ' Oxadiazols (nuclear localization viral matrix blockers), Preclinical, International Therapeutics ' Poly acrylic acid, Preclinical, Chinese Academy of Science ' Resveretrol (Egr1 gene activator), Preclinical, National Cancer Institute ' Rev inhibitors, Preclinical, National Institutes of Health ' RPI (nicotinic acetylcholine receptor blocker), Preclinical, NutraPharma ' RSC-1838, Preclinical, GlaxoSmithKline and Shionogi ' RWJ67567 (p38 inhibitor), Preclinical, University of Pennsylvania and Johnson & Johnson ' siRNA constructs (rev/tat inhibitors), Preclinical, Beckman Institute ' siRNA molecule, Preclinical, CombiMatrix ' TRIM5-alpha (capsid inhibitor), Preclinical, Dana Farber Cancer Institute-NIAID
From our Sponsors
Most Popular
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
The freedom of disclosure: David Anzuelo's journey through HIV, art, and advocacy
August 02 2024 12:21 PM
The Talk: Thriving with HIV
May 08 2024 10:45 AM
The Talk: What HIV isn’t
May 07 2024 10:48 AM
Plus: Featured Video
Latest Stories
How fitness coach Tyriek Taylor reclaims his power from HIV with self-commitment
September 19 2024 12:00 PM
Out100 Honoree Tony Valenzuela thanks queer and trans communities for support in his HIV journey
September 18 2024 12:00 PM
Kentucky bans conversion therapy for youth as Gov. Andy Beshear signs 'monumental' order
September 18 2024 11:13 AM
Why activist Raif Derrazi thinks his HIV diagnosis is a gift
September 17 2024 12:00 PM
Creator and host Karl Schmid fights HIV stigma with knowledge
September 12 2024 12:03 PM
Study finds use of puberty blockers safe and reversible, countering anti-trans accusations
September 11 2024 1:11 PM
Latinx health tips / Consejos de salud para latinos (in English & en espanol)
September 10 2024 4:29 PM
The Trevor Project receives $5M grant to support LGBTQ+ youth mental health in rural Midwest (exclusive)
September 03 2024 9:30 AM
Introducing 'Health PLUS Wellness': The Latinx Issue!
August 30 2024 3:06 PM
La ciencia detrás de U=U ha estado liberando a las personas con VIH durante años
August 23 2024 2:48 PM
Tratamiento y prevención del VIH por inyección: Todo lo que necesita saber
August 23 2024 2:41 PM
Sr. Gay World quiere asegurarse de que estés bien
August 23 2024 2:30 PM
Eureka is taking a break from competing on 'Drag Race' following 'CVTW' elimination
August 20 2024 12:21 PM
With a new case in Sweden, what is the new mpox outbreak and should you be concerned?
August 15 2024 4:48 PM
From ‘The Real World’ to real life: How Danny Roberts thrives with HIV
July 31 2024 5:23 PM
The July/Aug 'Treatment Guide' issue of Plus is here!
June 26 2024 3:49 PM
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM